Risk assessment and primary prevention of CVD

“The quality of what Pharmacy Management is putting on is simply streets ahead of anything else I’m seeing at the moment. Keep up the good work!”
Noel Wicks, Managing Director, Right Medicine Pharmacy Ltd, Stirling
Satellite Risk assessment and primary prevention of CVD
Speakers Sadeer Fhadil (Highly Specialist Cardiac Pharmacist - Cardiac Pharmacy Department, Barts Heart Centre, Barts Health NHS Trust)
Satellite Description

This talk will assess the impact of cardiovascular disease, discussing who to target and when. It will discuss various cardiovascular risk assessment tools and how to manage those at risk. Management will focus on key areas for CVD prevention; Atrial fibrillation, blood pressure and cholesterol, including non-pharmacological interventions. We will also discuss the controversial role of aspirin in primary prevention of CVD and review the evidence.

Foundation Level.

Back to Course

Connect with us Industry NHS


This site is intended for healthcare professionals or people employed in the pharmaceutical industry. Please confirm that you are such a person.